These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 18931845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
    Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S.
    N Engl J Med; 2000 Aug 17; 343(7):457-62. PubMed ID: 10950667
    [Abstract] [Full Text] [Related]

  • 4. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
    Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Minar E, Lechner K, Kyrle PA.
    Thromb Haemost; 1997 Apr 17; 77(4):624-8. PubMed ID: 9134632
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS.
    Saudi Med J; 2004 Jul 17; 25(7):848-51. PubMed ID: 15235686
    [Abstract] [Full Text] [Related]

  • 7. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2003 Aug 17; 3(3):303-14. PubMed ID: 15199464
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. D-dimer, oral anticoagulation, and venous thromboembolism recurrence.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2005 Nov 17; 5(4):365-70. PubMed ID: 16302157
    [Abstract] [Full Text] [Related]

  • 11. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W, Warfarin Optimal Duration Italian Trial Investigators.
    N Engl J Med; 2001 Jul 19; 345(3):165-9. PubMed ID: 11463010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlager T, Fuchssteiner H, Knoflach P, Vogelsang H, Miehsler W, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Eichinger S.
    Gastroenterology; 2010 Sep 19; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overweight, obesity, and the risk of recurrent venous thromboembolism.
    Eichinger S, Hron G, Bialonczyk C, Hirschl M, Minar E, Wagner O, Heinze G, Kyrle PA.
    Arch Intern Med; 2008 Aug 11; 168(15):1678-83. PubMed ID: 18695082
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar 11; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.